The National Alliance of Advocates
for Buprenorphine Treatment
Buprenorphine (Suboxone®, Subutex®) is an opioid medication used to treat opioid
addiction in the privacy of a physician's office.1 Buprenorphine can be dispensed
for take-home use, by prescription.1 This, in addition to the pharmacological
and safety
profile of buprenorphine, makes it an attractive treatment for patients addicted to opioids.2
NAABT, Inc. - Patient/Physician Matching System Privacy Policy
Privacy Policy:
Your privacy is of great concern to us (naabt.org) we will NEVER ask for your name, address or phone number. If you use the patient/physician matching system application, your email address will not be published nor made available to anyone at any time for any reason, it will be automatically converted to a NAABT ID# for your privacy and that is all the doctor or the doctor’s staff can see when evaluating your application for possible treatment availability.
You have the option to be removed from the list at any time. and can do so by logging in and checking the “ I no longer wish to be on the matching system/contacted by a physician” checkbox. We will not share your information with anyone or any company that is not a participating physician or their staff.
Depending on the security settings of your browser, small amounts of data called “cookies” may be placed on your hard drive. Cookies help make using the internet easier by remembering zip codes, passwords and pages visited. You have the option, on your computer system, to turn off cookies at any time if you wish.
Any electronic data is at some risk of theft, by computer hackers. Although we take precautions to prevent this we can never be 100% certain identifying email addresses can't be stolen. We suggest for added security you obtain an unidentifiable (one that does not contain your name or initials), free email address through Yahoo.com or Hotmail.com and forward it to your current email address. This way even in the rare event of theft, you cannot be identified by your email address.
- U.S. Food and Drug Administration, FDA Talk Paper, T0238, October 8, 2002, Subutex and Suboxone approved to treat opiate dependence.
- Center for Substance Abuse Treatment. Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04-3939. Rockville, Md: Substance Abuse and Mental Health Services Administration, 2004.